Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
METROPOLIS | BSE
-14.75
-0.88%
Healthcare
Diagnostics & Research
30/09/2023
08/12/2023
1,653.80
1,670.00
1,676.95
1,643.85
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing and profiles and support services. The company provides diagnostic services for oncology neurology gynecology and nephrology as well as various health check-up packages for men women senior citizens and youth and corporates. Its tests and profiles are used for prediction early detection diagnostic screening confirmation and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions as well as clinical research services. As of March 31 2022 it operated 171 clinical laboratories 9000 pick-up points and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak P/E, and PEG ratio indicator
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
16.7%1 month
24.8%3 months
32.0%6 months
29.6%63.70
40.82
8.09
0.22
0.15
29.54
7.44
0
2.26B
84.77B
1.02B
0.24
17.04
-12.10
2.70
13.34
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
112.90
Range1M
205.65
Range3M
358.70
Rel. volume
0.24
Price X volume
4.42M